The 2025 Nobel Prize in Physiology or Medicine has been awarded to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their pioneering discoveries that explain how the immune system learns to restrain itself — a process scientists call peripheral immune tolerance.

The trio’s work uncovered the biological mechanisms that stop the immune system from turning its weapons inward and attacking the body’s own cells — a failure of which lies behind autoimmune diseases such as diabetes, multiple sclerosis, and rheumatoid arthritis.

In announcing the prize at Stockholm’s Karolinska Institutet, the Nobel Committee praised the laureates for “revealing one of the most fundamental balancing acts of life — how immunity stays powerful yet peaceful.”

“These discoveries form the basis of a new era in immunology and medicine,” the committee said in its statement. “They have reshaped our understanding of self-tolerance and opened paths toward targeted treatments for autoimmune disease, transplantation, and cancer.”

The Science Behind the Discovery

The immune system’s mission is simple but perilous: it must attack dangerous invaders — viruses, bacteria, or cancerous cells — without harming the body’s own tissues. To achieve this, it develops a complex web of checks and balances.

For decades, scientists believed that immune tolerance — the body’s ability to distinguish between “self” and “foreign” — was determined early in life within the thymus, where self-reactive immune cells are deleted before they can cause harm.

But that explanation, known as central tolerance, turned out to be incomplete.

In the 1990s, Shimon Sakaguchi, a Japanese immunologist, discovered a mysterious subset of white blood cells that seemed to suppress excessive immune responses. He called them regulatory T cells, or Tregs — the body’s immune “brakes.”

Later, in 2001, Mary Brunkow and Fred Ramsdell, working independently at Immunex Corporation in the United States, identified a gene called Foxp3, mutations in which caused a fatal autoimmune disorder in mice. Around the same time, doctors found that mutations in the human version of this gene led to a rare but devastating condition known as IPEX syndrome, where the immune system destroys multiple organs in infants.

Their findings revealed that Foxp3 acts as a master switch — the genetic command center that gives Tregs their identity and suppressive power. Without it, the immune system cannot apply the brakes, and chaos ensues.

Together, Sakaguchi’s discovery of Tregs and Brunkow and Ramsdell’s genetic work on Foxp3 explained how the immune system maintains order in the body long after the thymus has done its job — a second, crucial layer of control known as peripheral immune tolerance.

Why It Matters

The implications of their work reach far beyond the lab bench.

1. A New Frontier in Treating Autoimmune Diseases

Autoimmune conditions — where the immune system attacks the body — affect hundreds of millions of people worldwide. Understanding how Tregs and Foxp3 function has inspired a wave of research into cell-based therapies designed to restore immune balance by boosting or engineering regulatory T cells.

Clinical trials are already underway for Treg therapies targeting type 1 diabetes, lupus, and multiple sclerosis, with early results showing promise in reducing inflammation without the harsh side effects of conventional immunosuppressive drugs.

2. Organ Transplantation Without Lifelong Drugs

Another tantalizing application lies in organ transplantation. Patients who receive donor organs must take lifelong immunosuppressants to prevent rejection, leaving them vulnerable to infection and cancer. Scientists hope that by harnessing regulatory T cells, doctors could one day induce true immune tolerance — allowing the body to accept a transplanted organ as its own.

3. Rethinking Cancer Immunotherapy

The same discovery also cuts both ways. In cancer, Tregs can act as protectors of the tumor, preventing the immune system from attacking malignant cells. By temporarily disabling these “brakes,” researchers are exploring ways to make immunotherapies more potent against cancer.

4. Balancing Immunity and Tolerance

The challenge, experts say, is to fine-tune the system — enhancing suppression where it’s excessive, and releasing the brakes where it’s too tight. “It’s a delicate dance,” said Dr. Lena Karlsson, an immunologist at Karolinska. “The immune system is like a high-performance car: you need both the accelerator and the brake to stay on the road.”

A Milestone in Modern Immunology

The Nobel recognition underscores how fundamental questions in biology — once purely theoretical — can lead to transformative medicine.

When Sakaguchi first proposed the existence of suppressive T cells three decades ago, the idea was controversial. Today, it forms the backbone of a new generation of precision immunotherapies.

Fred Ramsdell, now at Merck Research Laboratories, reflected in an interview that the discoveries were a reminder of the value of curiosity-driven science. “We weren’t trying to cure disease,” he said. “We were just trying to understand how the immune system keeps from destroying itself. The rest followed.”

Mary Brunkow, who began her work as a young scientist at Immunex, said she hoped the award would inspire more collaboration between basic researchers and clinicians. “The bridge between discovery and therapy is shorter than ever,” she said.

What’s next

The Nobel Prize in Medicine often signals not just a scientific triumph, but the dawn of a new therapeutic era. Just as discoveries in immunity led to vaccines, monoclonal antibodies, and checkpoint inhibitors, the insights from Brunkow, Ramsdell, and Sakaguchi could redefine how we treat diseases rooted in immune imbalance.

As the Nobel Committee concluded:

“Their discoveries have given medicine the tools to calm the storm — or unleash it when needed.”

In a century where both pandemics and autoimmune disorders threaten global health, understanding how to control the immune system without silencing it may prove to be one of the defining medical frontiers of our time.

For more visit: nobelprize.org/prizes/medicine

Mohsin Rasheed

Co-Founder & Chief Editor of Everyman Science. I view science not just as a collection of facts, but as the ultimate guide for human survival. From medical breakthroughs to the logistics of space exploration, I am dedicated to documenting how scientific reasoning uplifts the human spirit and provides the blueprints to save our planet. I believe that by unleashing the power of nature through disciplined inquiry, we can secure a sustainable future for humanity.

The post 2025 Nobel Prize in Medicine Honors Discoveries That Unlocked the Body’s Immune “Brakes” appeared first on Everyman Science.

The post 2025 Nobel Prize in Medicine Honors Discoveries That Unlocked the Body’s Immune “Brakes” appeared first on Everyman Science.

The World Before Life: A Soup of Chemicals

Imagine Earth, 4 billion years ago. There were no trees, no animals, no humans—just a bubbling mix of chemicals. Think of it like a huge chemical soup. Scientists call this the “prebiotic world”, which means the time before biology kicked in.

In this soup, tiny molecules floated around. Some of them were RNA, a cousin of DNA. RNA is like a strip of code that can carry information, and some forms of it can even do jobs—like tiny machines. These special RNAs are called ribozymes.

The Problem: Life Needs a Lot of Parts

Here’s the catch: for life to work, you need lots of different molecules doing specific jobs, all in the right place, at the right time. So how could a bunch of random chemicals organize themselves into something as complex as life?

One key idea scientists explore is cooperation—just like a team sport, where players need to pass the ball and help each other score.

But cooperation doesn’t just happen. Especially in molecules, where the “players” are floating around randomly and can easily get separated.

The Experiment: Helping Molecules Work Together

In this new study, researchers set up a clever experiment. They created two types of ribozymes (those RNA machines we mentioned earlier). Each one could help build a piece of the other—but not itself. That means they could only survive and keep going if they helped each other.

To simulate early Earth conditions, they used tiny bubbles called protocells—like microscopic soap bubbles that trap molecules inside. The idea is that if both ribozymes end up in the same bubble, they can team up and keep “reproducing.”

Here’s where it gets interesting: When both ribozymes made it into the same bubble, their partnership worked—and they thrived. But if only one type got inside, nothing happened. Cooperation was the key.

What This Tells Us About Life

This simple setup gives us a big insight: life might have started through teamwork between molecules, not just individual action. In other words, early life didn’t begin with one molecule doing everything. It may have started with molecular cooperation—a kind of molecular friendship where two or more pieces helped each other survive.

Even better, this teamwork likely happened inside tiny compartments (like those protocell bubbles), which kept the helpers close together and made cooperation easier.

Why This Matters

You might be thinking, “Okay, cool, but why does this matter now?” Well, understanding how life started isn’t just a fascinating thought experiment—it has real, modern-day implications. It helps guide our search for life beyond Earth, prompting scientists to look for similar chemical “soups” on planets like Mars or icy moons like Europa. It also plays a crucial role in efforts to create synthetic life in laboratories, which could one day revolutionize medicine, energy production, and materials science. And perhaps most importantly, it deepens our appreciation for just how fragile and extraordinary life truly is. This study brings us one step closer to answering that age-old, mind-blowing question: How did we go from lifeless molecules to a planet teeming with living, breathing creatures?

Chemistry + Time = Life?

Science is showing us that the path from simple molecules to complex life may have started with small steps—cooperation, chance meetings, and lucky bubbles.

In a way, life began not as a solo act, but as a duet. And from that first tiny team-up, everything else—trees, cats, humans, and even this article—followed.

Pretty amazing, right?

You can read the original research paper here: Applied Astrobiology: An Integrated Approach to the Future of Life in Space

Mohsin Rasheed

Co-Founder & Chief Editor of Everyman Science. I view science not just as a collection of facts, but as the ultimate guide for human survival. From medical breakthroughs to the logistics of space exploration, I am dedicated to documenting how scientific reasoning uplifts the human spirit and provides the blueprints to save our planet. I believe that by unleashing the power of nature through disciplined inquiry, we can secure a sustainable future for humanity.

The post How Teamwork Between Molecules May Have Sparked the Origin of Life appeared first on Everyman Science.

The post How Teamwork Between Molecules May Have Sparked the Origin of Life appeared first on Everyman Science.

For centuries, death has been seen as a definitive, irreversible event. The heart stops, the brain shuts down, and consciousness disappears. But a growing body of scientific research is challenging this assumption and opening a new chapter in our understanding of what it truly means to die.

At the forefront of this revolution is Dr. Sam Parnia, an intensive care physician, researcher, and director of resuscitation science at NYU Langone. As featured in the University of Chicago’s Big Brains podcast, Dr. Parnia’s work delves into the mysterious space between life and death—and what he’s discovering may one day redefine our very concept of human existence.

Is Death a Moment or a Process?

Our cultural understanding of death is strikingly black-and-white. A person is either alive or dead. One moment they are breathing, the next they are not. But as Dr. Parnia explains, this binary thinking is a social construct, not a biological reality.

“Death is not a moment. It is a process,” says Parnia. Like flying from day into night, the transition from life to death is gradual, not instant. Just because the heart stops does not mean the body immediately becomes irreversibly non-functional.

In fact, modern medical research shows that cells, including those in the brain, can remain viable for hours after cardiac arrest. This discovery has profound implications—not only for emergency medicine but for our philosophical and spiritual beliefs as well.

Death Reconsidered

Historically, questions about what happens after death were left to theologians and philosophers. But with advancements in neuroscience, artificial intelligence, and critical care medicine, science is stepping into the post-mortem arena.

Dr. Parnia argues that studying what happens after clinical death is not only scientific—it’s necessary. As he puts it: “The work I’m trying to do is to restore life in people after death. To do that, we have to understand consciousness.”

This isn’t science fiction. In one groundbreaking experiment led by Dr. Nenad Sestan at Yale University and published in Nature in 2019, researchers were able to restore cellular function to pig brains that had been dead for over 10 hours. Using a specialized cocktail of drugs and artificial blood flow, they showed that even the most complex organ in the body could potentially be revived.

Notably, these pig brains were given drugs to suppress consciousness—not because consciousness was impossible, but because it was ethically unacceptable to let them regain awareness. That choice alone hints at a paradigm shift: the boundary between life and death is much blurrier than we imagined.

Consciousness

Consciousness remains one of the great frontiers of science. Where does it come from? Can it survive beyond the body? Is it generated by neurons firing in the brain—or is it something more?

While no one has definitive answers, Dr. Parnia’s research suggests that consciousness can persist for minutes—perhaps even hours—after clinical death. He has conducted large-scale studies involving people who were revived after being declared dead, many of whom recalled vivid experiences during that time. These near-death experiences (NDEs) are often dismissed as hallucinations, but Parnia insists they are worthy of scientific exploration.

“There is no evidence that shows how electrical or chemical processes in brain cells lead to the emergence of consciousness,” he notes. “We can observe brain activity, but we can’t explain awareness.”

This mystery has led to two competing theories:

1. Consciousness is an emergent property of brain activity—a kind of byproduct of neurons communicating.
2. Consciousness is a fundamental aspect of the universe, not entirely dependent on the brain—more like radio waves picked up by the brain rather than created by it.

Neither theory has been proven. But Parnia’s work, and that of others in this emerging field, may eventually bridge the divide between science and spirituality.

A Future Where Death Isn’t Final?

Perhaps the most provocative aspect of Parnia’s work is its potential application. Imagine emergency responders armed with tools and protocols that could reverse death in many cases. People once considered beyond saving—heart attack victims, accident casualties—could be given a second chance at life.

“We’ve learned that if you know what to do, and how to do it, you can restore life—even after hours of death—with no brain damage,” Parnia explains. “The implications are massive.”

But the ethical and philosophical questions loom large. If we can bring someone back, are they still the same person? Does restoring brain function equal restoring the mind? And at what point do we accept death, not just as a medical reality but as a human one?

Key Takeaway

Dr. Sam Parnia and his colleagues are helping us peel back the veil that has shrouded death for millennia. Their work demands that we think more deeply about life, consciousness, and what it means to be human. While we are far from unlocking all the secrets of death, we are no longer in the dark. Science, once focused on prolonging life, is now learning how to reclaim it. And in doing so, it’s forcing us to reconsider one of the most fundamental truths we thought we knew. So maybe death isn’t the end of the story. Maybe it’s just the beginning of a new chapter—one that science is only now starting to write.

References & Acknowledgment:
This article was inspired by ““What Happens When We Die?” featuring Dr. Sam Parnia, hosted by Paul Rand on the Big Brains podcast, produced by the University of Chicago Podcast Network. We thank the original creators for their thoughtful exploration of life, death, and everything in between. Dr. Parnia is a co-author of “Erasing Death: The Science That Is Rewriting the Boundaries Between Life and Death” published in 2013.

Mohsin Rasheed

Co-Founder & Chief Editor of Everyman Science. I view science not just as a collection of facts, but as the ultimate guide for human survival. From medical breakthroughs to the logistics of space exploration, I am dedicated to documenting how scientific reasoning uplifts the human spirit and provides the blueprints to save our planet. I believe that by unleashing the power of nature through disciplined inquiry, we can secure a sustainable future for humanity.

The post What Science Says About Death and Consciousness – Dr. Sam Parnia appeared first on Everyman Science.

The post What Science Says About Death and Consciousness – Dr. Sam Parnia appeared first on Everyman Science.

Let’s break it down.

Who’s Behind the Buzz?

A Texas-based biotech startup named Colossal Biosciences made waves this week when they introduced three adorable wolf pups to the world—Romulus, Remus, and Khaleesi. Marketed as “resurrected” dire wolves, these pups are the result of a gene-editing project that modified gray wolf DNA.

But there’s a catch. While they may look a bit like their extinct cousins, experts warn these animals are far from being true dire wolves.

The Real Dire Wolf

Dire wolves (Aenocyon dirus) were very real—and very different from modern wolves. Living up until around 10,000 years ago, they were apex predators of the Late Pleistocene, roughly 20% larger than today’s gray wolves and equipped with strong jaws for tackling large prey.

Genetically, though? Totally different beasts. A groundbreaking 2021 study showed that dire wolves and gray wolves diverged almost 6 million years ago—around the same time our ancestors branched off from chimpanzees. So calling a gene-edited gray wolf a “dire wolf” is a bit like calling a person with a chimpanzee’s hair texture a new species of human.

What Did Colossal Actually Do?

Colossal’s team performed 20 genetic tweaks across 14 genes in gray wolves, hoping to replicate some dire wolf traits. That might sound like a lot—until you consider the millions of differences between the two species. Critics argue that calling this a de-extinction is not only misleading, but scientifically inaccurate.

Pontus Skoglund, a geneticist at the Francis Crick Institute, put it bluntly:

“Would a chimpanzee with 20 gene edits be considered human?”

If the answer’s no, then these edited wolves are no more dire wolves than a painted dog is a tiger.

Scientific Hype or Scientific Hope?

The backlash has been swift and strong. Some ecologists have slammed the project as ethically questionable and misleading, while science communicators have pointed out the dangers of selling hype as science.

YouTuber Hank Green, for example, noted that these animals aren’t being returned to the wild and couldn’t survive there anyway. Why? Because their prey is long gone. The ecosystem they once ruled has vanished.

What’s the Point, Then?

Despite the dramatic marketing, the science behind this isn’t without value. The gene-editing tools used here could be applied to conservation efforts in the real world.

Colossal is also working on projects like expanding the red wolf population in North Carolina and supporting the genetic diversity of bison. If handled responsibly, this technology could help endangered species survive—not by resurrecting the past, but by securing the future.

So, Should We Bring Extinct Species Back?

It’s a question that’s as much philosophical as it is scientific. Just because we might be able to recreate ancient DNA doesn’t mean we should—especially when living species are disappearing at an alarming rate due to human activities.

Instead of chasing ghost animals, many argue we should focus our energy and resources on preserving biodiversity before it vanishes. Rewilding isn’t about reanimation; it’s about rebalancing.

Science or Showbiz?

The return of the dire wolf makes for great headlines and even better Instagram posts. But when you scratch beneath the surface, what you find isn’t a scientific revolution—it’s a PR campaign wrapped in a lab coat. That doesn’t mean the technology is useless or evil. But let’s call it what it is: genetic mimicry, not resurrection.

At Everyman Science, we believe science should illuminate—not mislead. And while we cheer on advances in conservation biology, we also believe that clarity and honesty are just as vital as innovation.

Mohsin Rasheed

Co-Founder & Chief Editor of Everyman Science. I view science not just as a collection of facts, but as the ultimate guide for human survival. From medical breakthroughs to the logistics of space exploration, I am dedicated to documenting how scientific reasoning uplifts the human spirit and provides the blueprints to save our planet. I believe that by unleashing the power of nature through disciplined inquiry, we can secure a sustainable future for humanity.

The post The “Dire” Truth About De-Extinction: Scientists Slam ‘Recreated’ Wolves as Genetic Stunts appeared first on Everyman Science.

The post The “Dire” Truth About De-Extinction: Scientists Slam ‘Recreated’ Wolves as Genetic Stunts appeared first on Everyman Science.

Understanding the Winners

David Baker: Architect of New Proteins

David Baker, a professor at the University of Washington in Seattle, has made significant strides in the design of new proteins. His inventive approach involves the creation of entirely new types of proteins, which were previously unimaginable in nature. Baker’s research group has been at the forefront of this innovative field, developing imaginative protein designs that could play crucial roles in various sectors, including pharmaceuticals, vaccines, nanomaterials, and sensors.

The implications of Baker’s work are profound, as his engineered proteins may pave the way for new treatments and technologies, emphasizing the vital role of protein research in addressing global challenges as antibiotics resistant bacteria.

Demis Hassabis and John Jumper: AI and Protein Structure Prediction

On the other hand, Demis Hassabis and John Jumper, both associated with Google DeepMind in London, have made remarkable contributions through their groundbreaking AI model known as AlphaFold2. This model has transformed the landscape of protein structure prediction, enabling scientists to anticipate the shapes of nearly all known proteins—over 200 million in total.

The accuracy of AlphaFold2 has far-reaching implications for biological research, including insights into antibiotic resistance and the visualization of enzymes that can break down plastic. Such advancements are critical in our understanding of complex biological processes and the development of solutions to pressing environmental issues.

Related: Hopfield and Hinton Win 2024 Nobel Prize for Breakthroughs in Machine Learning

The Significance of Protein Research

Proteins: The Building Blocks of Life

Proteins are integral to the functioning of all living organisms. Often described as nature’s “ingenious chemical tools,” they facilitate and govern the chemical reactions that sustain life. Proteins have diverse roles, ranging from acting as hormones and signaling molecules to serving as antibodies and foundational components of tissues. The work conducted by Baker, Hassabis, and Jumper not only enhances our understanding of these vital molecules, but it also opens vast new possibilities for their applications in science and medicine.

The Nobel Prize: A Recognition of Groundbreaking Discoveries

The 2024 Nobel Prize in Chemistry comes with a total prize amount of 11 million Swedish kronor. David Baker receives half of this sum, while the other half is equally shared between Demis Hassabis and John Jumper, reflecting the collaborative nature of their groundbreaking research endeavors.

This recognition by the Nobel Committee for Chemistry highlights not only the monumental discoveries made by these scientists but also their potential to significantly impact various fields, from biotechnology to environmental science.

The awarding of the Nobel Prize in Chemistry to David Baker, Demis Hassabis, and John Jumper is a testament to the extraordinary advances in protein research and the potential it holds for the future. Their groundbreaking work not only deepens our understanding of life’s fundamental processes but also sets the stage for innovative solutions to some of the world’s most pressing challenges. As we continue to explore the complexities of proteins and their structures, the contributions of these researchers will undoubtedly inspire and drive future developments in science.

Here is an official press release from nobelprize.org.

Also Read: Ambros & Ruvkun’s MicroRNA Breakthrough Wins 2024 Nobel Prize in Physiology & Medicine

Mohsin Rasheed

Co-Founder & Chief Editor of Everyman Science. I view science not just as a collection of facts, but as the ultimate guide for human survival. From medical breakthroughs to the logistics of space exploration, I am dedicated to documenting how scientific reasoning uplifts the human spirit and provides the blueprints to save our planet. I believe that by unleashing the power of nature through disciplined inquiry, we can secure a sustainable future for humanity.

The post 2024 Nobel Prize in Chemistry Awarded for Breakthroughs in Protein Research appeared first on Everyman Science.

The post 2024 Nobel Prize in Chemistry Awarded for Breakthroughs in Protein Research appeared first on Everyman Science.

Anatomy and Characteristics

They are the sole members of their family, Xiphiidae. The name “swordfish” pays homage to their distinct long, sword-like bill. While they may share similarities with other billfish like marlins, they differ physiologically and belong to separate families. Extinct genera such as Xiphiorhynchus and Aglyptorhynchus, which had even longer lower jaws compared to modern swordfish, have also been identified.

Swordfish exhibit remarkable temperature regulation abilities, heating their eyes to temperatures significantly higher than that of the surrounding water through special organs near their eyes. This heating process, which can improve their vision, is unique to only 22 fish species, including swordfish. Additionally, swordfish are ectothermic and have the capacity to conserve heat.

Feeding Habits and Speed

Swordfish are solitary swimmers or, at most, swim in sparse groups. They display unique feeding habits, hunting prey with their impressive speed and agility. Although the notorious claim of reaching speeds of 100 km/h (60 mph) is unreliable, their speed is more accurately estimated at around 36 km/h (22 mph). They are mostly nocturnal feeders, often swimming to the surface in search of smaller fish. Squid and various types of fish make up their diet, and swordfish spend much of their time at depths of up to 550 m during the day.

Threats and Conservation

Their population faces various threats, with almost 50 parasite species documented in swordfish. Despite having minimal natural predators as adults, they are heavily targeted by human fisheries. Efforts have been made to conserve swordfish populations, with a ban on long-lining in place in many areas to aid their recovery from overfishing.

Swordfish are widely adored as a culinary delicacy but caution is advised due to potential toxicity from high mercury levels in their meat. The firm texture of their meat makes it suitable for grilling or cooking in various ways. There is some debate within the Jewish community concerning the kosher status of swordfish, with opinions varying among different authorities and communities. For conservation purposes, it has been specified as a species of moderate to high concern in various regions due to overfishing and uncertain stock status. Greenpeace International has also listed swordfish on its seafood red list.

The swordfish remains a revered icon in the aquatic realm, admired for its unparalleled speed and unique characteristics. With careful management and conservation efforts, they will continue to enchant and captivate seekers of both sport and gastronomy alike.

Mohsin Rasheed

Co-Founder & Chief Editor of Everyman Science. I view science not just as a collection of facts, but as the ultimate guide for human survival. From medical breakthroughs to the logistics of space exploration, I am dedicated to documenting how scientific reasoning uplifts the human spirit and provides the blueprints to save our planet. I believe that by unleashing the power of nature through disciplined inquiry, we can secure a sustainable future for humanity.

The post Swordfish: Predators of the Deep appeared first on Everyman Science.

The post Swordfish: Predators of the Deep appeared first on Everyman Science.